Publications by authors named "Dafni Meimaridou"
Background: Adjustment of the initial dose of paricalcitol in hemodialysis patients with secondary hyperparathyroidism (SHPT) on the basis of severity of SHPT generally is preferred in current practice. Whether the proposed dose, based on the formula baseline intact parathyroid hormone (iPTH [picograms per milliliter]) divided by 80, is the most appropriate has not been assessed adequately.
Methods: A double-blind randomized trial comparing iPTH/80 dose with the immediately lower iPTH/120 dose was undertaken.
Objective: The clinical efficacy of therapeutic apheresis is still controversial. We undertook a retrospective review of apheresis treatment to ascertain its safety and efficacy.
Methods: We reviewed 31 patients (13 male, 18 female).